Editorial: Quantitative [ 18 F]NaF PET in metastatic and metabolic bone diseases.

Autor:	Puri T; Faculty of Biology, Medicine and Health, School of Medical Sciences, Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, United Kingdom., Moore AE; Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, United Kingdom., Mahajan A; The Clatterbridge Cancer Centre NHS Foundation Trust, University of Liverpool, Liverpool, United Kingdom., McWilliam A; Faculty of Biology, Medicine and Health, School of Medical Sciences, Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom., Vrist MH; Gødstrup Hospital, University Clinic in Nephrology and Hypertension, Herning, Denmark., Blake GM; Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, United Kingdom.
Jazyk:	angličtina
Zdroj:	Frontiers in nuclear medicine (Lausanne, Switzerland) [Front Nucl Med] 2023 Dec 11; Vol. 3, pp. 1343913. Date of Electronic Publication: 2023 Dec 11 (Print Publication: 2023).
DOI:	10.3389/fnume.2023.1343913
Abstrakt:	Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu